Bio

Isaiah joined ArchiMed’s New York office in March 2022. Isaiah previously was an investor with K2 Health Ventures and Madryn Asset Management in New York, focusing on debt and equity growth capital investments in biotechnology, life science, and medical device companies. Isaiah gained operating experience as a finance consultant to the CFO of Butterfly Network, a SaaS based point-of-care ultrasound company, assisting in taking the company public. He began his career as a healthcare Investment Banker at MTS Health Partners and a consultant at IQVIA. Isaiah received his Master of Business Administration from Columbia Business School and graduated cum laude with dual Bachelor of Science degrees in Biology and Economics from Cornell University. He is a United States citizen.